Almirall Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALMIRALL, and when can generic versions of ALMIRALL drugs launch?
ALMIRALL has twelve approved drugs.
There are twenty US patents protecting ALMIRALL drugs.
There are two hundred and eleven patent family members on ALMIRALL drugs in thirty-one countries and thirty-one supplementary protection certificates in fourteen countries.
Drugs and US Patents for Almirall
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almirall | VERDESO | desonide | AEROSOL, FOAM;TOPICAL | 021978-001 | Sep 19, 2006 | DISCN | Yes | No | 8,962,000 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Almirall | SEYSARA | sarecycline hydrochloride | TABLET;ORAL | 209521-002 | Oct 1, 2018 | RX | Yes | No | 8,318,706 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Almirall | ACZONE | dapsone | GEL;TOPICAL | 207154-001 | Feb 24, 2016 | AB | RX | Yes | Yes | 9,517,219 | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Almirall
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Almirall | SOLAGE | mequinol; tretinoin | SOLUTION;TOPICAL | 020922-001 | Dec 10, 1999 | 5,194,247 | ⤷ Try a Trial |
Almirall | AZELEX | azelaic acid | CREAM;TOPICAL | 020428-001 | Sep 13, 1995 | 4,386,104 | ⤷ Try a Trial |
Almirall | SOLAGE | mequinol; tretinoin | SOLUTION;TOPICAL | 020922-001 | Dec 10, 1999 | 5,470,567 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALMIRALL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Gel | 7.5% | ➤ Subscribe | 2017-02-13 |
International Patents for Almirall Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Russian Federation | 2015123207 | ⤷ Try a Trial |
Hong Kong | 1188985 | ⤷ Try a Trial |
Spain | 2463457 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Almirall Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1836169 | SPC/GB22/002 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TIRBANIBULIN; REGISTERED: UK EU/1/21/1558(FOR NI) 20210719; UK FURTHER MA ON IPSUM 20210719 |
1304992 | 92401 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
1028961 | 07C0057 | France | ⤷ Try a Trial | PRODUCT NAME: RETAPAMULIN; REGISTRATION NO/DATE IN FRANCE: EU/1/07/390/001 DU 20070524; REGISTRATION NO/DATE AT EEC: EU/1/07/390/001 DU 20070524 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.